4//SEC Filing
Poulton Stuart 4
Accession 0001209191-23-044040
CIK 0001503802other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:37 PM ET
Size
5.0 KB
Accession
0001209191-23-044040
Insider Transaction Report
Form 4
Poulton Stuart
EVP, Chief Development Officer
Transactions
- Sale
Common Stock
2023-07-28$1.70/sh−2,845$4,837→ 156,286 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001942597
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:37 PM ET
- Size
- 5.0 KB